Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 1, Janvier 2007
Page(s) 88 - 92
Section Dossier technique
DOI https://doi.org/10.1051/medsci/200723188
Publié en ligne 15 janvier 2007
  1. Mirowski M, Reid PR, Mower MM, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. N Engl J Med 1980; 303 : 322–4.
  2. The antiarrhythmics versus implantable defibrillator (AVID) investigators. A comparison of antiarrhythmic drug therapy with implantable defibrillator in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 33 : 1576–83.
  3. Connolly SJ, Jent M, Roberts RS, et al. Canadian implantable defibrillators study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against Amiodarone. Circulation 2000; 101 : 1297–302.
  4. Kuck KH, Cappato R, Sibels J, et al. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest. The cardiac arrest study Hambourg (CASH). Circulation 2000; 102 : 748–54.
  5. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials: AVID, CASH and CIDS studies. Eur Heart J 2000; 21 : 2071–8.
  6. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 1996; 335 : 1933–40.
  7. Bigger JT. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 1997; 337 : 1569–75.
  8. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardy trial investigators. N Engl J Med 1999; 341 : 1882–90.
  9. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346 : 877–83.
  10. Bansch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. Circulation 2002; 105 : 1453–8.
  11. Strickberger SA, Hummel JD, Bartlett TG, et al. Amiodarone versus implantable cardioverter defibrillator : randomized trial in patients with non ischemic dilated cardiomyopathy and asymptomatic non sustained ventricular tachycardia. AMIOVIRT. J Am Coll Cardiol 2003; 41 : 1707–12.
  12. Bristow MR, Saxon LA, Boehmer J, et al. Comparison of medical therapy, pacing and defibrilltion in heart failure (COMPANION) investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350 : 2140–50.
  13. Kadish A, Dyer A, Daubert JP, et al for the defibrillators in non ischemic cardiomyopathy treatment evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with non ischemic dilated cardiomyopathy. N Engl J Med 2004; 350 : 2151–8.
  14. Bardy GH, Lee KL, Markd B, et al. Sudden cardiac death in heart failure trial (SCD-HeFT) investigators. Amiodarone or/and implantable cardioverter defibrillator for congestive heart failure. N Engl J Med 2005; 352 : 225–37.
  15. Hohnloser SH, Kuck KH, Dorian P, et al. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med 2004; 351 : 2480–8.
  16. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction. A pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004; 44 : 2166–72.
  17. Aliot E, Frank R, Chauvin M, et al. Indications du défibrillateur automatique implantable ventriculaire : mises à jour de la version française. Arch Mal Cœur 2006, 99 : 141–54.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.